https://cvvr.hms.harvard.edu/wp-content/uploads/2020/07/WP.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-06-01 12:28:202022-06-02 12:29:26There’s still no HIV vaccine. The science behind coronavirus shots may help.
“Ongoing transmission of BA.2 is probably related both to the increased transmissibility of the virus together with the reduction of pandemic restrictions,” says Dan Barouch. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/12/National-Geo.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-04-25 08:42:302022-04-26 08:44:24Here’s what we know about the BA.2 Omicron subvariant driving a new COVID-19 wave
In the face of waning antibody immunity to the coronavirus, scientists demand more attention on T cell immunity which may be more durable. Read article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/Boston-globe.jpg240240Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-04-24 16:34:222022-04-24 16:34:22Scientists to FDA: Don’t forget about T cells
A lab study published last week found that vaccinated people who were infected with Omicron, a COVID-19 variant, had high levels of antibodies that would probably protect against BA.2. If […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-03-19 09:47:462022-03-22 09:49:16Another Covid Surge May Be Coming. Are We Ready for It?
This week, Pfizer and Moderna asked the FDA to authorize fourth doses of their vaccines. Meanwhile, a new study shows protection from one J&J shot lasts at least six months. […]
While the number of cases of the Omicron variant has been decreasing over the past few weeks, health officials are concerned about the BA.2 variant, which appears to be more […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2022/02/WBZ-Radio-news.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-02-24 09:58:532022-02-28 10:09:06New Studies Shed Light On The Severity And Transmissibility Of BA.2 Variant
While the rise of another strain has some Americans stressed over the prospect of yet another wave of cases, it may not be time to panic just yet. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2022/02/NY-Mag.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-02-19 09:33:302022-02-21 09:35:31How Worried Should We Be About the BA.2 Omicron Subvariant?
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2022-02-04 08:59:412022-02-15 09:01:40Younger Americans Benefited Less From Booster Shots Than Older People
There’s still no HIV vaccine. The science behind coronavirus shots may help.
/in News“I’m not afraid to say that I cried,” recalled Stephenson, a researcher at Beth Israel Deaconess Medical Center in Boston. Read Article
Here’s what we know about the BA.2 Omicron subvariant driving a new COVID-19 wave
/in News“Ongoing transmission of BA.2 is probably related both to the increased transmissibility of the virus together with the reduction of pandemic restrictions,” says Dan Barouch. Read Article
Scientists to FDA: Don’t forget about T cells
/in NewsIn the face of waning antibody immunity to the coronavirus, scientists demand more attention on T cell immunity which may be more durable. Read article
HU CFAR Newsletter- April 2022
/in NewsAnother Covid Surge May Be Coming. Are We Ready for It?
/in NewsA lab study published last week found that vaccinated people who were infected with Omicron, a COVID-19 variant, had high levels of antibodies that would probably protect against BA.2. If […]
As picture of Covid vaccine durability gets clearer, J&J makes a strong showing
/in NewsThis week, Pfizer and Moderna asked the FDA to authorize fourth doses of their vaccines. Meanwhile, a new study shows protection from one J&J shot lasts at least six months. […]
New Studies Shed Light On The Severity And Transmissibility Of BA.2 Variant
/in NewsWhile the number of cases of the Omicron variant has been decreasing over the past few weeks, health officials are concerned about the BA.2 variant, which appears to be more […]
How Worried Should We Be About the BA.2 Omicron Subvariant?
/in NewsWhile the rise of another strain has some Americans stressed over the prospect of yet another wave of cases, it may not be time to panic just yet. Read Article
New Covid Variants Complicate the Question of Vaccine Mandates
/in NewsOfficials mulling new pandemic policies need to know how quickly vaccine protection wanes. But scientists don’t have a clear answer. Read Article
Younger Americans Benefited Less From Booster Shots Than Older People
/in NewsAmong those under age 50, vaccination even without a booster protected strongly against hospitalization and death.. Read Article